|
From Discovery to Medicine
A unit of the Academic Health Center, Molecular and Cellular Therapeutics offers state-of-the-art GMP/GTP compliant, full-service development and manufacturing of cell- and tissue-based products, monoclonal antibodies and other therapeutic proteins, as well as active pharmaceutical ingredients, for use in Phase I, II or III clinical trials. Our fully-staffed technical and quality personnel with over 70 years of combined cell-based products experience, through product development and technical expertise, as well as medical and regulatory support, work to compress development timelines and translate research into medicine.
|

|
In the News: New hope for childhood leukemia
|